4-traders.com, stock quotes, stock exchange, market price, stock market advice, technical analysis, stock chart analysis, Company News

Member access

Equities
Indexes
- Europe
  
  FTSE 100
  DAX
  CAC 40
  BEL 20
  ATHEX COMP
  RUSLAND RTS
  SMI
  IBEX 35
  MILANO MIB
  AEX
  PSI 20
  POLAND WIG
- Asia, Pacific
  
  NIKKEI 225
  SHANGHAI COMP
  HANG SENG
  KOSPI COMP
  SENSEX
  TAIWAN TWSE
  THAILAND 50
  SYDNEY ASX
- Middle East
  
  EGX 30
  TELAVIV 25
Commodities
- Metals
  
  GOLD
  SILVER
  PLATINUM
  PALLADIUM
  ALUMINIUM
  COPPER
  LEAD
  TIN
  ZINC
- Agriculture
  
  COFFEE
  SUGAR
  CORN
  COCOA
  COTTOM
  WHEAT
  PALM IOL
  SOYBEANS
Currencies
News
- Companies
  
  All News
  Press Releases
  Events
  Corporate actions
- Economy & Forex
  
  All News
  Currencies / Forex
  Economic Events
  Press releases
Analysis
Top & Flop
Market Screener
- Technical Analysis
  
  Oversold stocks
  Overbought stocks
  Close to resistances
  Close to supports
  Accumulation phase
  Most volatile stocks
- Fundamentals
  
  Top Investor Rating
  Top Trading Rating
  Top Consensus
  Growth stocks
  Yield stocks
  Low valuations
Calendar
- Finance Calendar
- Economic Calendar

4-Traders Homepage > Shares > Nasdaq > Amylin Pharmaceuticals LLC AMLN US0323461089

AMYLIN PHARMACEUTICALS LLC

(AMLN)

6

Delayed Nasdaq - 08/08 04:00:02 pm
30.98	USD		-0.06%

2012

AMYLIN PHARMACEUTICALS, INC.: Bristol-Myers Squibb and AstraZeneca Complet..

2012

DJ

Eli Lilly To Record $1.26 Billion Benefit from Amylin

2012

DJ

ASTRAZENECA: Bristol-Myers Squibb Completes Purchase of Amylin

Target Price consensus revisions : last 18 months

Amylin Pharmaceuticals LLC : Target Price consensus revisions : last 18 months

Larger Image

Evolution of the average goal on AMYLIN PHARMACEUTICALS LLC

Data source :
© 2013 Thomson Reuters

Advertisement

Dynamic quotes | OFF

My Watchlist|My Portfolio

4-traders.com :

About :

Copyright © 2013 Surperformance. All rights reserved.